THE IMPACT OF PSORIASIS ON MENTAL AND SOCIAL WELL-BEING: A LITERATURE REVIEW FROM A PSYCHODERMATOLOGICAL PERSPECTIVE
Abstract
Psoriasis, a chronic inflammatory skin disease, poses challenges not only due to its somatic symptoms but also because of its significant impact on patients’ quality of life, mental health, and social and occupational functioning. This review aimed to analyze the multidimensional influence of psoriasis on patients’ psychosocial condition, with particular attention to stigmatization, symptoms of depression and anxiety, suicide risk, and factors affecting quality of life. The analysis is based on up-to-date literature from systematic reviews, cross-sectional and qualitative studies published between 2010 and 2025. Findings indicate that patients with psoriasis are significantly more likely to experience depressive and anxiety disorders, often regardless of lesion severity. Subjective factors such as body image perception, social stigma, loss of control over one’s body, and limitations in professional life play a crucial role. Importantly, some patients exhibit suicidal ideation at early stages of the disease, even before treatment begins. Simultaneously, evidence points to the necessity of an integrated care model that includes dermatological, psychological, and social support. Incorporating mental health and quality of life assessments into routine clinical practice can significantly improve treatment outcomes and patient well-being. This review emphasizes the need for a holistic approach to psoriasis management that addresses not only physical but also psychological and social dimensions.
References
Boehncke, W.-H., & Schön, M. P. (2015). Psoriasis. The Lancet, 386(9997), 983–994. https://doi.org/10.1016/S0140-6736(14)61909-7
Raharja, A., Mahil, S. K., & Barker, J. N. (2021). Psoriasis: a brief overview. Clinical Medicine, 21(3), 170–173. https://doi.org/10.7861/clinmed.2021-0257
Purzycka-Bohdan, D., Kisielnicka, A., Zabłotna, M., Nedoszytko, B., Nowicki, R. J., Reich, A., Samotij, D., Szczech, J., Krasowska, D., Bartosińska, J., Narbutt, J., Lesiak, A., Barasińska, P., Owczarczyk-Saczonek, A., Czerwińska, J., Szepietowski, J. C., Batycka-Baran, A., Czajkowski, R., Górecka-Sokołowska, M., ... Szczerkowska-Dobosz, A. (2022). Chronic plaque psoriasis in Poland: Disease severity, prevalence of comorbidities, and quality of life. Journal of Clinical Medicine, 11(5), 1254. https://doi.org/10.3390/jcm11051254
Lim, D. S. Y., Bewley, A., & Oon, H. H. (2018). Psychological profile of patients with psoriasis. Annals, Academy of Medicine, Singapore, 47(12), 516–522. https://doi.org/10.47102/annals-acadmedsg.v47n12p516
Nguyen, C. M., Beroukhim, K., Danesh, M. J., Babikian, A., Koo, J., & Leon, A. (2016). The psychosocial impact of acne, vitiligo, and psoriasis: a review. Clinical, Cosmetic and Investigational Dermatology, 9, 383–392. https://doi.org/10.2147/CCID.S76088
Cohen, B. E., Martires, K. J., & Ho, R. S. (2016). Psoriasis and the risk of depression in the US population: National Health and Nutrition Examination Survey 2009–2012. JAMA Dermatology, 152(1), 73–79. https://doi.org/10.1001/jamadermatol.2015.3605
Fabrazzo, M., Romano, F., Arrigo, M., Puca, R. V., Fuschillo, A., De Santis, V., Sampogna, G., Giordano, G. M., Catapano, F., & Lo Schiavo, A. (2022). A multivariate analysis of depression prevalence in psoriasis patients: A cohort study. International Journal of Environmental Research and Public Health, 19(4), 2060. https://doi.org/10.3390/ijerph19042060
Schuster, B., Peifer, C., Ziehfreund, S., Tizek, L., Biedermann, T., Zink, A., & Schielein, M. C. (2022). Happiness and depression in psoriasis: A cross-sectional study in Germany. Quality of Life Research, 31(7), 1761–1773. https://doi.org/10.1007/s11136-021-02991-2
Hölsken, S., Krefting, F., Schedlowski, M., & Sondermann, W. (2021). Common fundamentals of psoriasis and depression. Acta Dermato-Venereologica, 101, adv00609. https://doi.org/10.2340/actadv.v101.565
Sahi, F. M., Masood, A., Danawar, N. A., Mekaiel, A., & Malik, B. H. (2020). Association between psoriasis and depression: A traditional review. Cureus, 12(8), e9708. https://doi.org/10.7759/cureus.9708
Strober, B., Gooderham, M., de Jong, E. M. G. J., Kimball, A. B., Langley, R. G., Lakdawala, N., ... & Menter, A. (2018). Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR). Journal of the American Academy of Dermatology, 78(1), 70–80. https://doi.org/10.1016/j.jaad.2017.08.051
Pompili, M., Innamorati, M., Trovarelli, S., Narcisi, A., Bellini, S., Orsini, D., Forte, A., Erbuto, D., Botti, E., Lamis, D. A., Girardi, P., & Costanzo, A. (2016). Suicide risk and psychiatric comorbidity in patients with psoriasis. Journal of International Medical Research, 44(1_suppl), 61–66. https://doi.org/10.1177/0300060515593253
Ghani, H., Tan, I. J., & Abramowitz, C. (2023). The association between psoriasis and suicide. Dermatological Reviews, 4(1), e209. https://doi.org/10.1002/der2.209
Jalenques, I., Bourlot, F., Martinez, E., Pereira, B., D’Incan, M., Lauron, S., & Rondepierre, F. (2022). Prevalence and odds of anxiety disorders and anxiety symptoms in children and adults with psoriasis: Systematic review and meta-analysis. Acta Dermato-Venereologica, 102, adv00769. https://doi.org/10.2340/actadv.v102.1386
Bakar, R. S., Jaapar, S. Z. S., Azmi, A. F., & Aun, Y. C. (2021). Depression and anxiety among patients with psoriasis: A correlation with quality of life and associated factors. Journal of Taibah University Medical Sciences, 16(4), 491–496. https://doi.org/10.1016/j.jtumed.2021.02.008
Ferreira, B. I. R. C., Abreu, J. L. P. C., dos Reis, J. P. G., & Figueiredo, A. M. C. (2016). Psoriasis and associated psychiatric disorders: A systematic review on etiopathogenesis and clinical correlation. Journal of Clinical and Aesthetic Dermatology, 9(6), 36–43. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928455/
Gisondi, P., Puig, L., Richard, M. A., Paul, C., Nijsten, T., Taieb, C., Stratigos, A., Trakatelli, M., Salavastru, C., & EADV Burden of Skin Diseases Project Team. (2023). Quality of life and stigmatization in people with skin diseases in Europe: A large survey from the ‘burden of skin diseases’ EADV project. Journal of the European Academy of Dermatology and Venereology, 37(Suppl. 7), 6–14. https://doi.org/10.1111/jdv.18917
Meneguin, S., de Godoy, N. A., Pollo, C. F., Miot, H. A., & de Oliveira, C. (2020). Quality of life of patients living with psoriasis: A qualitative study. BMC Dermatology, 20(1), 22. https://doi.org/10.1186/s12895-020-00116-9
Jung, S., Lee, S. M., Suh, D., Shin, H. T., & Suh, D. C. (2018). The association of socioeconomic and clinical characteristics with health-related quality of life in patients with psoriasis: a cross-sectional study. Health and Quality of Life Outcomes, 16(180). https://doi.org/10.1186/s12955-018-1007-7
Jankowiak, B., Kowalewska, B., Khvorik, D. F., Krajewska-Kułak, E., & Niczyporuk, W. (2016). The level of stigmatization and depression of patients with psoriasis. Iranian Journal of Public Health, 45(5), 690–692. http://ijph.tums.ac.ir
Zhang, H., Yang, Z., Tang, K., Sun, Q., & Jin, H. (2021). Stigmatization in patients with psoriasis: A mini review. Frontiers in Immunology, 12, 715839. https://doi.org/10.3389/fimmu.2021.715839
Decean, L., Badea, M., Rus, V., Buicu, G., Sasu, A., Pilut, C. N., & Mihai, A. (2022). The implication of misinformation and stigma in age-related quality of life, depression, and coping mechanisms of adult patients with psoriasis. Medicina, 58(10), 1420. https://doi.org/10.3390/medicina58101420
Kowalewska, B., Jankowiak, B., Cybulski, M., Krajewska-Kułak, E., & Khvorik, D. F. (2021). Effect of disease severity on the quality of life and sense of stigmatization in psoriatics. Clinical, Cosmetic and Investigational Dermatology, 14, 107–121. https://doi.org/10.2147/CCID.S286312
Kowalewska, B., Cybulski, M., Jankowiak, B., & Krajewska-Kułak, E. (2020). Acceptance of illness, satisfaction with life, sense of stigmatization, and quality of life among people with psoriasis: A cross-sectional study. Dermatology and Therapy, 10(1), 413–430. https://doi.org/10.1007/s13555-020-00368-w
Yélamos, O., Ros, S., & Puig, L. (2015). Improving patient outcomes in psoriasis: Strategies to ensure treatment adherence. Psoriasis: Targets and Therapy, 5, 109–115. https://doi.org/10.2147/PTT.S54070
Blackstone, B., Patel, R., & Bewley, A. (2022). Assessing and improving psychological well-being in psoriasis: Considerations for the clinician. Psoriasis: Targets and Therapy, 12, 25–33. https://doi.org/10.2147/PTT.S328447
van Beugen, S., Ferwerda, M., Spillekom-van Koulil, S., Smit, J. V., Zeeuwen-Franssen, M. E. J., Kroft, E. B. M., de Jong, E. M. G. J., Otero, M. E., Donders, A. R. T., van de Kerkhof, P. C. M., van Middendorp, H., & Evers, A. W. M. (2016). Tailored therapist-guided internet-based cognitive behavioral treatment for psoriasis: A randomized controlled trial. Psychotherapy and Psychosomatics, 85(5), 297–307. https://doi.org/10.1159/000447267
Gisondi, P., Del Giglio, M., & Girolomoni, G. (2017). Treatment approaches to moderate to severe psoriasis. International Journal of Molecular Sciences, 18(11), 2427. https://doi.org/10.3390/ijms18112427
Belinchón, I., Rivera, R., Blanch, C., Comellas, M., & Lizán, L. (2016). Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: A systematic review of the literature. Patient Preference and Adherence, 10, 2357–2367. https://doi.org/10.2147/PPA.S117006
Spillekom-van Koulil, S., Ferwerda, M., van Beugen, S., van Middendorp, H., van de Kerkhof, P. C. M., van Riel, P. L. C. M., & Evers, A. W. M. (2018). Tailored therapist-guided internet-based cognitive-behavioural treatment for psoriasis and rheumatoid arthritis: Two case reports. Acta Dermato-Venereologica, 98(2), 225–233. https://doi.org/10.2340/00015555-2803
Views:
32
Downloads:
21
Copyright (c) 2025 Agnieszka Waszczuk, Paweł Sosnowski, Mateusz Świątko, Anna Tokarska, Marcin Grzebyk, Aleksandra Arnista, Joanna Rybak, Katarzyna Gawrońska, Aleksandra Kołodziejczyk, Piotr Łapiński
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
